Outcomes | Methods | OR | (95% CI) | P value |
---|---|---|---|---|
COVID-19 susceptibility (COVID-19 vs. population) | Inverse variance weighted | 1.024 | 1.004–1.045 | 0.017 |
MR Egger | 1.064 | 0.933–1.214 | 0.418 | |
Weighted median | 1.029 | 1.003–1.055 | 0.024 | |
Weighted mode | 1.031 | 0.998–1.066 | 0.135 | |
COVID-19 severity (Hospitalized vs. population) | Inverse variance weighted | 1.025 | 1.001–1.049 | 0.039 |
MR Egger | 1.053 | 0.893–1.240 | 0.580 | |
Weighted median | 1.030 | 1.003–1.058 | 0.027 | |
Weighted mode | 1.046 | 0.999–1.094 | 0.139 | |
COVID-19 severity (Very severe respiratory confirmed vs. not hospitalized) | Inverse variance weighted | 0.964 | 0.797–1.166 | 0.711 |
MR Egger | 1.305 | 0.356–4.784 | 0.713 | |
Weighted median | 1.004 | 0.784–1.287 | 0.967 | |
Weighted mode | 1.087 | 0.789–1.499 | 0.652 |